Related Experiment Video
Updated: Aug 11, 2026

Creation and Transplantation of an Adipose-derived Stem Cell (ASC) Sheet in a Diabetic Wound-healing Model
Published on: August 4, 2017
Platelet-derived growth factor levels in wounds of diabetic rats
1Department of Biomedical Sciences, Baylor College of Dentistry, Dallas, Texas 75266-0677, USA.
Abstract:
Delayed wound healing is a troublesome complication of Diabetes. Results from recent investigations concerning the potential cellular and molecular mechanisms responsible for diabetic wound healing deficiency are preliminary in nature. Some studies have demonstrated that direct application of certain growth factors/cytokines can facilitate wound healing in diabetic models. It is possible that refractory diabetic wounds are the result of deficiencies in growth factors/cytokines important for the normal wound healing process. Platelet-Derived Growth Factor (PDGF) levels were examined by radioimmunoassay in wound tissue of normal and diabetic rats (streptozotocin-induced diabetes). Immunohistochemical analysis was utilized to localize and characterize PDGF immunopositive cells at the wound site of normal and diabetic animals. At the wound site, normal animals demonstrated significantly elevated PDGF levels compared to diabetic animals at 5 days post-wounding (no differences were observed in the spleen or contralateral control tissue). There appeared to be a visible increase in PDGF immunopositive cells at the wound site in both experimental and control groups. By day 10 post-wounding, PDGF levels at the wound site in normal animals were reduced becoming similar to PDGF levels in diabetic animals. This corresponded to an apparent reduction of PDGF immunopositive cells in both groups (similar to baseline levels). PDGF levels in both groups remained stable until day 20 post-wounding when a significant elevation of wound site PDGF levels occurred in the diabetic group. The findings suggest that absence of an initial increase in PDGF may play an important role in poor wound healing observed in diabetic animals. The reduction in PDGF may be related to decreased cellular PDGF production rather than a lack of PDGF-producing cells. Perhaps the diabetic state inhibits cellular PDGF gene expression signaled by wounding or interferes with normal PDGF expression at the wound site.
Insights
Diabetic wound healing is impaired due to low initial levels of Platelet-Derived Growth Factor (PDGF). This suggests reduced PDGF production, not a lack of cells, hinders healing in diabetes.
Area of Science:
- Biomedical Science
- Wound Healing Research
- Diabetes Complications
Background:
- Delayed wound healing is a significant complication in diabetes.
- The precise cellular and molecular mechanisms are not fully understood.
- Growth factors may play a crucial role in diabetic wound repair.
Purpose of the Study:
- To investigate Platelet-Derived Growth Factor (PDGF) levels in diabetic wound healing.
- To compare PDGF expression in normal versus diabetic rat wound models.
- To explore the role of PDGF in the delayed healing observed in diabetes.
Main Methods:
- Radioimmunoassay was used to quantify PDGF levels in wound tissue.
- Immunohistochemical analysis identified PDGF-producing cells.
- Streptozotocin-induced diabetes model in rats was employed.
Main Results:
- Diabetic rats showed significantly lower PDGF levels at the wound site on day 5 post-wounding compared to normal rats.
- Both groups exhibited an increase in PDGF-immunopositive cells, with levels normalizing by day 10.
- Diabetic wounds showed a late elevation in PDGF on day 20, unlike normal wounds.
Conclusions:
- An initial deficit in PDGF at the wound site may contribute to impaired diabetic wound healing.
- Reduced PDGF levels in diabetes might stem from decreased cellular production or gene expression inhibition.
- Further research is needed to understand PDGF regulation in diabetic wound repair.
Related Concept Videos
Diabetic Foot Ulcer
Diabetic Retinopathy

